Terray Therapeutics

Terray Therapeutics

Edit info

  • Founded: 2018
  • Location: Pasadena, CA
  • Employee range: 11 - 50
  • Clinical stage: Clin0
  • Therapy area: Retinitis pigmentosa
  • Drug types: OPH, GEN
  • Lead product: RTx-015
  • Funding: $60M Feb 2022


terraytx.com

linkedin.com

job board


Drug notes:

Also Clin0 inherited retinal degenerations; RTx-021 Clin0 geographic atrophy

About:

Terray Therapeutics is using AI-technology to drive drug discovery. To develop a therapeutic engine, Terray is generating chemical data purpose-built for drug discovery that is integrated into their computational platform, tNova. tNova runs iterative cycles of virtual molecular design and precise biochemical measurement. This data feeds forward to power machine learning models that guide the next cycle of design. With a chemistry engine that measures billions of interactions daily and becomes increasingly precise, Terray can answer various biological questions and derive insights to predictably create drugs for patients. This virtual approach enables Terray to work on a large scale, faster than previously possible.

Jobs:

Terray Therapeutics
Senior Scientist, Molecular Design
(Onsite) Monrovia, CA|46 days ago
Apply
Terray Therapeutics
Senior Scientist, Medicinal Chemistry
Monrovia, CA|100+ days ago


© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy

Contact: recruit@workinbiotech.com